IP Library Granted Patent US 7,745,686
Granted Patent B2
US 7,745,686 · App. 10/003,915 · Granted Jun 29, 2010

Catamenial device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,745,686
App. No.
10/003,915
Granted
Jun 29, 2010
Kind
B2
Abstract

There is provided a fibrous absorbent article for absorbing body fluids made up of a fibrous material defining a structure suitable for absorbing the body fluids, and disposed within the structure an effective amount, so as to reduce Staphylococcus aureus bacterial growth and neutralize TSS toxin-1 within the vagina, of one or more antimicrobial agents and one or more finishing agents.

Claims (18)

1. A tampon comprising an absorbent material and a composition disposed in said absorbent material, the composition comprising:

at least one antibacterial agent in an amount of about 0.10 wt % to about 2.5 wt % of the total weight of the tampon, wherein said antibacterial agent is a mixture of alkyl dimethyl benzylammonium chloride and alkyl dimethyl ethylbenzylammonium chloride; and

at least one finishing agent in an amount of about 2.5 wt % of the total weight of the tampon, wherein said at least one finishing agent is one or more polyoxyethylene fatty acid esters,

wherein the composition has synergistic antibacterial properties effective to neutralize the production of TSST-1 toxin and reduce Staphylococcus aureus bacteria growth.

2. The tampon of claim 1 , wherein said at least one antibacterial agent is present in an amount of about 1.0 wt.% based on the total weight of the tampon.

3. The tampon of claim 1 , wherein said composition further comprises one or more additional components selected from the group consisting of: preservative, deodorant, fragrance, malodor counteractant material, humectant, and any combinations thereof.

4. The tampon of claim 1 , wherein said composition consists essentially of:

about 0.10 wt % to about 2.5 wt %, based on the total weight of the tampon, of a mixture of alkyl dimethyl benzylammonium chloride and alkyl dimethyl ethylbenzylammonium chloride; and

about 2.5 wt %, based on the total weight of the tampon, of one or more polyoxyethylene fatty acid esters.

5. A method of inhibiting the production of TSST-1 toxin by exposing TSST-1 toxin-producing Staphylococcus aureus bacteria to a tampon, the tampon having an absorbent material and a composition, the composition comprising:

at least one antibacterial agent in an amount of about 0.10 wt % to about 2.5 wt % of the total weight of the tampon, wherein said antibacterial agent is a mixture of alkyl dimethyl benzylammonium chloride and alkyl dimethyl ethylbenzylammonium chloride; and

at least one finishing agent in an amount of about 2.5 wt % of the total weight of the tampon, wherein said at least one finishing agent is one or more polyoxyethylene fatty acid esters;

wherein the composition has synergistic antibacterial properties effective to neutralize the production of TSST-1 toxin and reduce Staphylococcus aureus bacteria growth.

6. The method of claim 5 , wherein said at least one antibacterial agent is present in an amount about 1.0 wt. % based on the total weight of the tampon.

7. The method of claim 5 , wherein said composition further comprises one or more additional components selected from the group consisting of: preservative, deodorant, fragrance, malodor counteractant material, humectant and any combinations thereof.

8. The method of claim 5 , wherein said composition consists essentially of:

about 0.10 wt % to about 2.5 wt %, based on the total weight of the tampon, of a mixture of alkyl dimethyl benzylammonium chloride and alkyl dimethyl ethylbenzylammonium chloride; and

about 2.5 wt %, based on the total weight of the tampon, of one or more polyoxyethylene fatty acid esters.

Assignments (8)
SECURITY AGREEMENT Recorded Apr 8, 2020
From: EDGEWELL PERSONAL CARE BRANDS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 052341/0735 →
CHANGE OF NAME Recorded Aug 16, 2017
From: EVEREADY BATTERY COMPANY, INC
To: EVEREADY BATTERY COMPANY, LLC
Reel/Frame 043571/0118 →
CHANGE OF NAME Recorded Aug 16, 2017
From: EVEREADY BATTERY COMPANY, LLC
To: EGDEWELL PERSONAL CARE BRANDS, LLC
Reel/Frame 043571/0987 →
RELEASE OF SECURITY INTEREST Recorded Jul 18, 2017
From: GENERAL ELECTRIC CAPITAL CORPORATION; GE CANADA FINANCE HOLDING COMPANY; WELLS FARGO BANK, NATIONAL ASSOCIATION
To: PLAYTEX PRODUCTS, INC; TANNING RESEARCH LABORATORIES, INC
Reel/Frame 043230/0546 →
SECURITY INTEREST Recorded Dec 7, 2005
From: PLAYTEX PRODUCTS, INC.
To: GE CANADA FINANCE HOLDING COMPANY
Reel/Frame 016862/0334 →
SECURITY INTEREST Recorded Mar 3, 2004
From: PLAYTEX PRODUCTS, INC.
To: WELLS FARGO BANK MINNESOTA, NATIONAL ASSOCIATION
Reel/Frame 014990/0309 →
SECURITY INTEREST Recorded Feb 27, 2004
From: PLAYTEX PRODUCTS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 014394/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2001
From: MAURO, ANTHONY J.; ROSENGARTEN, MARK E.; BUTENSKY, IRWIN
To: PLAYTEX PRODUCTS, INC.
Reel/Frame 012359/0471 →